Adamas Pharmaceuticals, Inc.: Launched GOCOVRI™ for LID in patients w/ Parkinson’s disease. Late-stage pipeline includes ADS-5102 in P3 for MS walking impairment and ADS-4101, high-dose, modified release lacosamide, which completed P1 for partial onset seizures in patients with epilepsy.
Website:
Address:
1900 Powell St, Ste 1000
Emeryville, CA 94608
United States

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2017 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.